Gap junction protein vital to successful pregnancy, researchers find

This is the first study to detail the mechanism by which the steroid hormone estrogen spurs cell differentiation and blood-vessel growth in the uterus during pregnancy, the researchers report.

The findings, from researchers at the University of Illinois, Emory University, Baylor College of Medicine and New York University, appear in the journal Development.

Connexin 43 (Cx43) belongs to a family of proteins that form junctions between cells that regulate the flow of ions and small signaling molecules from cell to cell. At the time of embryo implantation, this gap junction protein is essential to the rapid growth of new blood vessels needed to support the development of the embryo and allow it to implant in the uterine wall, the researchers discovered.

The researchers chose to study Cx43 after analyzing genes that are activated in the presence of estrogen in uterine cells. They found that Cx43 was prominent among the genes whose expression was increased in cells after exposure to estrogen.

University of Illinois veterinary biosciences doctoral student Mary Laws studied the role of Cx43 in pregnant mice and in human endometrial cells. By deleting the Cx43 gene in the uterus immediately after pregnancy in mice, a technique developed by researchers at Baylor, Laws was able to reliably prevent implantation of the embryo in the uterus.

In human endometrial cells (provided by co-author Robert Taylor of Emory University), Cx43 enhanced the differentiation of cells that make up the stromal tissue of the uterus. These cells produce factors that promote the growth of new blood vessels.

One of the factors secreted by the endometrial cells, vascular endothelial growth factor (VEGF), is essential to angiogenesis. In the absence of Cx43, Laws found, the cells failed to differentiate or to produce enough VEGF to spur blood vessel growth.

"The formation of these new blood vessels is extremely critical for embryonic growth at this stage of pregnancy, when the embryo has begun to invade into the uterine tissue, but has yet to make a connection to the placenta where it ultimately gets its nutrients," said Illinois veterinary biosciences professor Indrani Bagchi, corresponding author on the study. "I think this is the first animal model that shows that disruption of one particular molecule or gene leads to a defect in uterine angiogenesis."

The findings have important implications for early pregnancy loss and female infertility, she said.

"A fundamental aspect of female reproductive biology is how these hormones signal in uterine tissue in order to support the pregnancy," said molecular and integrative physiology professor Milan Bagchi, an author on the study. "One of our major goals is to identify the genes that are regulated by estrogen and progesterone precisely at the time when the embryo implants in the uterine wall."

"Connexin 43 has been shown to be in the uterus in many animal systems – cows and pigs and rodents and humans," Laws said. "But this is the first time that it's been shown to be critical for pregnancy."

Source: University of Illinois at Urbana-Champaign

Gene by gene, scientists dig for the triggers
James Thomson knew that to send a cell back to its past was no trivial matter. Like generations of biologists, the University of Wisconsin-Madison stem cell pioneer had been taught that development was a one-way street; it began with an embryo and finished with all the mature cells that make up the body. Yet in the summer of 2007, Thomson and scientists around the globe were racing to do what once had been thought impossible: to reverse the natural process and return old cells to their embryonic origin. They sought the healing potential of embryonic stem cells - immortal in a lab dish, able to become any cell in the body - but without the controversial destruction of human embryos.
What you give, might not always be received
A fundamental process in the transmission of genes from mother to child has been identified by researchers at the Montreal Neurological Institute, McGill University. The new study published in the December issue of the journal Nature Genetics identifies a mechanism that plays a key role in how mutations are transmitted from one generation to the next, providing unprecedented insight into metabolic diseases.
Harm-reduction cigarettes are more toxic than traditional cigarettes, study finds
Typically, tobacco companies market harm-reduction cigarettes as being safer than traditional "full-flavored" brands, leading many smokers to conclude that the use of harm-reduction brands lowers their exposure to toxicants.
'Embryo adoption' service seeks to give infertile couples a chance to have a family
The day the frozen embryo arrived via FedEx was the day Maria Lancaster began experiencing firsthand what she had always believed: that human life begins at conception.
Scientists identify possible cause of endometriosis
Endometriosis is a condition whereby patches of the inner lining of the womb appear in parts of the body other than the womb cavity. It can cause severe pain and affects approximately 15% of women of reproductive age. Endometriosis is also associated with infertility, with 50% of infertile women affected by the condition.
Normal-looking sperm may have serious damage; scientists urge more care in selection
Intracytoplasmic sperm injection (ICSI), where a single sperm is injected into an egg to fertilise it, is increasingly used to help infertile men father children. Although the sperm chosen for the procedure may appear quite normal, researchers in the US have found that many of them in fact have DNA damage, which can decrease the chances of pregnancy.
Stem cell discovery sheds light on placenta development
Researchers studying embryonic stem cells have explored the first fork in the developmental road, getting a new look at what happens when fertilized eggs differentiate to build either an embryo or a placenta.
First use of DNA fingerprinting to identify viable embryos
Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. The technique, combined with sampling cells from blastocysts (the very early embryo) before implantation in the womb, opens the way to pin-pointing a handful of genes that could be used to identify those blastocysts most likely to result in a successful pregnancy.

Gap junction protein vital to successful pregnancy, researchers find

Related stories:

News discussion: